Hydrix Ventures
Investing in
extraordinary
medical technologies
We invest where we can make the biggest difference, backing medical technologies that have the power to transform care and save lives.
Our portfolio companies
Wavewise Analytics (formerly Cyban)
A non-invasive continuous tissue oxygen monitor measuring cerebral (brain oxygen) in intensive care and ED.
Gyder Surgical
An intra-operative surgical navigation system to assist surgeons position implants during total hip arthroplasty.
Memphasys
Felix, a unique technology to separate high quality sperm for improved IVF procedures.
Hydrix Ventures supports a select group of early-stage medtech companies with both capital and in-kind development services, helping to refine and commercialise breakthrough technologies.
Leveraging Hydrix’s product realisation expertise, we work closely with our portfolio partners to accelerate progress, create value, and bring life-changing innovations to patients. While our current focus is on supporting existing investments, we’re always open to conversations with medtech founders where there’s strong alignment and potential to collaborate.